Cargando…
Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a painful, dose-limiting adverse effect of commonly used chemotherapeutic agents. The purpose of this exploratory study was to evaluate the efficacy and safety of mirogabalin in patients with moderate to severe CIPN during chemotherapy...
Autores principales: | Misawa, Sonoko, Denda, Tadamichi, Kodama, Sho, Suzuki, Takuji, Naito, Yoichi, Kogawa, Takahiro, Takada, Mamoru, Suichi, Tomoki, Shiosakai, Kazuhito, Kuwabara, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640752/ https://www.ncbi.nlm.nih.gov/pubmed/37951905 http://dx.doi.org/10.1186/s12885-023-11560-4 |
Ejemplares similares
-
Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study
por: Nikaido, Takuya, et al.
Publicado: (2022) -
Correction to: Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study
por: Nikaido, Takuya, et al.
Publicado: (2022) -
Fasciculation intensity and limb dominance in amyotrophic lateral sclerosis: a muscle ultrasonographic study
por: Suzuki, Yo-ichi, et al.
Publicado: (2022) -
Validation of the 2021 EAN/PNS diagnostic criteria for chronic inflammatory demyelinating polyneuropathy
por: Kuwabara, Satoshi, et al.
Publicado: (2022) -
Mirogabalin treatment of postoperative neuropathic pain after thoracic surgery: study protocol for a multicenter, randomized, open-label, parallel-group, interventional trial
por: Doi, Ryoichiro, et al.
Publicado: (2021)